On December 8, 2023, the U.S. Food and Drug Administration (FDA) approved the first-ever gene therapy that can treat patients with sickle cell disease, an inherited blood disorder. Vertex and CRISPR Therapeutics developed exagamglogene autotemcel … Bővebben: The world’s first gene-editing therapy to cure sickle cell disease